PRB2 | Proline-rich protein BstNI subfamily 2 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
PRB1 | Proline-rich protein BstNI subfamily 1 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
PRB4 | Proline-rich protein BstNI subfamily 4 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
PRB3 | Proline-rich protein BstNI subfamily 3 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
LELP1 | Late cornified envelope-like proline-rich 1 | | ![](/images/46932/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46932/106239_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
TUBA3C | Tubulin, alpha 3c | | ![](/images/39247/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43684/102075_A_1_8_rna_selected_60x60.jpg) | Tissue enriched |
PRM2 | Protamine 2 | | | ![](/images_static/na_center.gif) | ![](/images/56386/ihc_cell_selected_60x60.jpg) | ![](/images/32738/82019_A_2_6_rna_selected_60x60.jpg) | Tissue enriched |
BPIFA2 | BPI fold containing family A, member 2 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/44006/ihc_cell_selected_60x60.jpg) | ![](/images/44006/142418_B_3_4_rna_selected_60x60.jpg) | Tissue enriched |
HMGB4 | High mobility group box 4 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35699/101087_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/54698/133719_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
SPP2 | Secreted phosphoprotein 2, 24kDa | Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
NPPB | Natriuretic peptide B | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images/54960/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
CFHR2 | Complement factor H-related 2 | Plasma proteins Predicted secreted proteins
| | ![](/images/38915/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38915/103187_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
BOD1L2 | Biorientation of chromosomes in cell division 1-like 2 | | ![](/images/36293/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36293/73837_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
PRH2 | Proline-rich protein HaeIII subfamily 2 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
F9 | Coagulation factor IX | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
PGA5 | Pepsinogen 5, group I (pepsinogen A) | Enzymes Predicted secreted proteins
| ![](/images/46875/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46875/118030_B_8_7_rna_selected_60x60.jpg) | Tissue enriched |
PGA3 | Pepsinogen 3, group I (pepsinogen A) | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46875/118030_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
PRM1 | Protamine 1 | | ![](/images/55150/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/55150/125941_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
PGK2 | Phosphoglycerate kinase 2 | Enzymes Plasma proteins
| ![](/images/45385/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45385/102543_B_7_8_rna_selected_60x60.jpg) | Tissue enriched |
CA6 | Carbonic anhydrase VI | Enzymes Predicted secreted proteins
| | ![](/images/28550/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/28550/63023_B_1_8_rna_selected_60x60.jpg) | Tissue enriched |
AKAP4 | A kinase (PRKA) anchor protein 4 | Cytoskeleton related proteins
| | ![](/images/5949/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/20046/47383_B_2_3_rna_selected_60x60.jpg) | Tissue enriched |
MBL2 | Mannose-binding lectin (protein C) 2, soluble | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/16782/ihc_cell_selected_60x60.jpg) | ![](/images/16782/37033_A_3_6_rna_selected_60x60.jpg) | Tissue enriched |
PGA4 | Pepsinogen 4, group I (pepsinogen A) | Enzymes Predicted secreted proteins
| ![](/images/46875/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46875/118030_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
TNP1 | Transition protein 1 (during histone to protamine replacement) | | | ![](/images_static/na_center.gif) | ![](/images/44387/ihc_cell_selected_60x60.jpg) | ![](/images/44387/121824_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
SHCBP1L | SHC SH2-domain binding protein 1-like | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36125/142125_A_2_4_rna_selected_60x60.jpg) | Tissue enriched |
SPATA8 | Spermatogenesis associated 8 | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
SFTPA1 | Surfactant protein A1 | Disease related genes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42638/111943_A_2_7_rna_selected_60x60.jpg) | Tissue enriched |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/1524/4371_B_7_3_rna_selected_60x60.jpg) | Tissue enriched |
TPD52L3 | Tumor protein D52-like 3 | | ![](/images/23435/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/23435/50953_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
AC007557.1 | HCG1816075; Uncharacterized protein | | ![](/images/56677/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/56677/130272_A_3_8_rna_selected_60x60.jpg) | Tissue enriched |
UBQLN3 | Ubiquilin 3 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20547/47123_B_7_7_rna_selected_60x60.jpg) | Tissue enriched |
CETN1 | Centrin, EF-hand protein, 1 | | ![](/images/37244/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28956/67370_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
HTN3 | Histatin 3 | Predicted secreted proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
CYP11B1 | Cytochrome P450, family 11, subfamily B, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49171/142129_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
HTN1 | Histatin 1 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
ACTL7A | Actin-like 7A | Cytoskeleton related proteins
| | | ![](/images/21624/ihc_cell_selected_60x60.jpg) | ![](/images/21624/49060_B_9_7_rna_selected_60x60.jpg) | Tissue enriched |
ADAD1 | Adenosine deaminase domain containing 1 (testis-specific) | | ![](/images/44080/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44080/97838_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
APOC4 | Apolipoprotein C-IV | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62671/144049_B_8_4_rna_selected_60x60.jpg) | Tissue enriched |
KLK3 | Kallikrein-related peptidase 3 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/70/ihc_cell_selected_60x60.jpg) | ![](/images/764/1934_B_7_8_rna_selected_60x60.jpg) | Tissue enriched |
C4orf40 | Chromosome 4 open reading frame 40 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36151/142426_B_3_4_rna_selected_60x60.jpg) | Tissue enriched |
TMEM174 | Transmembrane protein 174 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37975/146511_A_3_4_rna_selected_60x60.jpg) | Tissue enriched |
GIF | Gastric intrinsic factor (vitamin B synthesis) | Disease related genes Predicted secreted proteins
| | ![](/images/40774/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39908/87834_A_5_5_rna_selected_60x60.jpg) | Tissue enriched |
CTRB2 | Chymotrypsinogen B2 | Enzymes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
C9 | Complement component 9 | Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images/29577/ihc_selected_60x60.jpg) | | ![](/images/2151/ihc_cell_selected_60x60.jpg) | ![](/images/2151/5802_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
PNLIPRP1 | Pancreatic lipase-related protein 1 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
SMR3A | Submaxillary gland androgen regulated protein 3A | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44567/151920_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
TEX38 | Testis expressed 38 | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
SPATA3 | Spermatogenesis associated 3 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18254/41365_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
SLC22A8 | Solute carrier family 22 (organic anion transporter), member 8 | FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/44174/ihc_cell_selected_60x60.jpg) | ![](/images/44174/147449_A_7_6_rna_selected_60x60.jpg) | Tissue enriched |